Literature DB >> 24136333

Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension.

Gustavo A Heresi1, Metin Aytekin, Jeffrey P Hammel, Sihe Wang, Soumya Chatterjee, Raed A Dweik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24136333     DOI： 10.1183/09031936.00164713

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  25 in total

1.  Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.

Authors:  Mary K Porteous; James C Lee; David J Lederer; Scott M Palmer; Edward Cantu; Rupal J Shah; Scarlett L Bellamy; Vibha N Lama; Sangeeta M Bhorade; Maria M Crespo; John F McDyer; Keith M Wille; A Russell Localio; Jonathan B Orens; Pali D Shah; Ann B Weinacker; Selim Arcasoy; David S Wilkes; Lorraine B Ware; Jason D Christie; Steven M Kawut; Joshua M Diamond
Journal:  Ann Am Thorac Soc       Date:  2017-10

Review 2.  Inflammation in Pulmonary Arterial Hypertension.

Authors:  Timothy Klouda; Ke Yuan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Gustavo A Heresi; Steven K Malin; Jarrod W Barnes; Liping Tian; John P Kirwan; Raed A Dweik
Journal:  Ann Am Thorac Soc       Date:  2017-02

Review 4.  Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch; Christophe Guignabert; Marc Humbert; Mark R Nicolls
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

5.  Endothelial-to-Mesenchymal Transition and Inflammation Play Key Roles in Cyclophilin A-Induced Pulmonary Arterial Hypertension.

Authors:  Chao Xue; Sharon Senchanthisai; Mark Sowden; Jinjiang Pang; Jim White; Bradford C Berk
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

6.  BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.

Authors:  Leanda Vengethasamy; Aurélie Hautefort; Birger Tielemans; Catharina Belge; Frédéric Perros; Stijn Verleden; Elie Fadel; Dirk Van Raemdonck; Marion Delcroix; Rozenn Quarck
Journal:  Pflugers Arch       Date:  2016-11-06       Impact factor: 3.657

7.  Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension.

Authors:  Kurt W Prins; Stephen L Archer; Marc Pritzker; Lauren Rose; E Kenneth Weir; Alok Sharma; Thenappan Thenappan
Journal:  J Heart Lung Transplant       Date:  2017-09-01       Impact factor: 10.247

8.  Association between IL-6 and related risk factors of metabolic syndrome and cardiovascular disease in young rats.

Authors:  Pengli Bao; Geli Liu; Ying Wei
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  Systemic Arterial Stiffness in New Diagnosed Idiopathic Pulmonary Arterial Hypertension Patients.

Authors:  G D Radchenko; I O Zhyvylo; E Y Titov; Yuriy M Sirenko
Journal:  Vasc Health Risk Manag       Date:  2020-01-16

10.  Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension.

Authors:  Catherine E Simpson; Jenny Y Chen; Rachel L Damico; Paul M Hassoun; Lisa J Martin; Jun Yang; Melanie Nies; Megan Griffiths; R Dhananjay Vaidya; Stephanie Brandal; Michael W Pauciulo; Katie A Lutz; Anna W Coleman; Eric D Austin; Dunbar D Ivy; William C Nichols; Allen D Everett
Journal:  Eur Respir J       Date:  2020-04-16       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.